Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea
· Delayed Price · Currency is KRW
10,020
+420 (4.38%)
Sep 11, 2024, 3:00 PM KST
Pharos iBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 129,448 | 191,588 | - | - | - | - |
Enterprise Value | 110,134 | 164,210 | - | - | - | - |
Last Close Price | 10020.00 | 14830.00 | - | - | - | - |
PE Ratio | - | -20.26 | - | - | - | - |
PB Ratio | 5.66 | 6.76 | - | - | - | - |
P/FCF Ratio | -13.24 | -23.22 | - | - | - | - |
P/OCF Ratio | -14.52 | -25.84 | - | - | - | - |
EV/EBITDA Ratio | -10.14 | -17.41 | - | - | - | - |
EV/EBIT Ratio | -9.52 | -16.23 | - | - | - | - |
EV/FCF Ratio | -10.50 | -19.90 | - | - | - | - |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | -0.04 | -0.68 | -0.33 |
Debt / FCF Ratio | -0.02 | -0.04 | -0.04 | -0.07 | -0.11 | -0.29 |
Asset Turnover | - | - | 0.01 | 0.00 | 0.02 | - |
Quick Ratio | 25.28 | 21.15 | 16.06 | 0.56 | 0.86 | 0.59 |
Current Ratio | 25.90 | 21.57 | 16.53 | 0.57 | 0.88 | 0.64 |
Return on Equity (ROE) | - | -38.50% | -1825.61% | - | - | - |
Return on Assets (ROA) | - | -26.12% | -28.73% | -23.78% | -32.64% | - |
Return on Capital (ROIC) | - | -27.09% | -469.65% | - | - | - |
Earnings Yield | -8.17% | -4.62% | - | - | - | - |
FCF Yield | -8.10% | -4.31% | - | - | - | - |
Buyback Yield / Dilution | -24.42% | -36.26% | -53.03% | -2.65% | -1.86% | - |
Total Shareholder Return | -24.42% | -36.26% | -53.03% | -2.65% | -1.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.